Janus Henderson Group PLC Aurinia Pharmaceuticals Inc. Transaction History
Janus Henderson Group PLC
- $194 Billion
- Q2 2025
A detailed history of Janus Henderson Group PLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 221,536 shares of AUPH stock, worth $2.69 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
221,536
Previous 49,331
349.08%
Holding current value
$2.69 Million
Previous $396,000
373.74%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding AUPH
# of Institutions
249Shares Held
62.6MCall Options Held
1.03MPut Options Held
666K-
Tang Capital Management LLC San Diego, CA10MShares$122 Million5.09% of portfolio
-
Black Rock Inc. New York, NY9.27MShares$112 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$48.1 Million2.79% of portfolio
-
State Street Corp Boston, MA2.8MShares$33.9 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.4MShares$29 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.72B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...